MediPoint: Viscosupplementation – South America Analysis and Market Forecasts

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint’s cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in South America (Argentina, Brazil, and Chile). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered in This Report:

~ What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the South American market?
~ Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
~ What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?
~ What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?
~ What are the challenges and complications that have hindered widespread adoption?
~ With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?

Scope

~ Overview of recent key industry events and analysis of their market impact.
~ Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.
~ Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.
~ Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
~ Analysis of the current and future market competition in the South American viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to:

~ Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.
~ Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.
~ Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.
~ Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
~ Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
~ Track device sales in country-specific viscosupplementation markets from 2014-2023.
~ Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies mentioned

Anika Therapeutics
Ferring Pharmaceuticals
Fidia Farmaceutici
Sanofi
Seikagaku Corporation
More than 20 others mentioned…….

Pages: 26       Published: April’ 2017       Format: Electronic PDF       Pricing: $5,000 (Single User)

To procure a copy or for more info, please feel free to Contact Us

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s